Skip to main content
Top

18-12-2024 | Research

The impact of a low-calorie, reduced-fat diet on liver attenuation imaging: a randomized clinical trial

Authors: Renjie Li, Jie Li, Danni He, Yajuan Sui, Wenfen Liu, Wentao Li, Wenyi Meng, Jiahui Peng, Zuofeng Xu

Published in: Abdominal Radiology

Login to get access

Abstract

Purpose

To investigate whether a low-calorie, reduced-fat diet affects liver attenuation imaging (ATI) measurements.

Methods

A total of 320 participants were enrolled in this prospective study. They were randomly assigned to four groups: a fasting group, a postprandial 0.5-hour examination group, a postprandial 2-hour examination group, and a postprandial 4-hour examination group. All participants first underwent liver ATI examination in a fasting state. Those in the postprandial groups then consumed a low-calorie, reduced-fat diet before undergoing a second ATI examination at 0.5 h, 2 h, or 4 h after the meal. The ATI values were compared among the groups. The differences between postprandial and fasting ATI values were also analyzed for the postprandial groups. Additionally, the consistency of the grading diagnosis of hepatic steatosis between the postprandial and fasting states was evaluated in the postprandial groups.

Results

The ATI values for the 0.5 h postprandial group, 2 h postprandial group, and 4 h postprandial group were not significantly different from those of the fasting group (P = 0.576, 0.471, and 0.992, respectively). No significant differences were noted in the ATI values recorded during the postprandial and fasting states within each of the postprandial groups (P = 0.573, 0.076, and 0.805, respectively). The kappa values for diagnostic consistency between the postprandial and fasting states across the three divergent criteria were 0.833–0.951, 0.812–0.855, and 0.737–0.862, respectively.

Conclusion

A low-calorie, reduced-fat diet does not significantly affect liver ATI measurements or the grading of hepatic steatosis. However, the lack of representation of older adults and populations with higher BMIs in this study may limit its generalizability, with the lack of external validation as a limitation. These issues should be tested and confirmed in further studies.

Clinical trial number

(ChiCTR2200062314, August 2022)
Appendix
Available only for authorised users
Literature
9.
go back to reference Dioguardi Burgio M, Castera L, Oufighou M, Rautou PE, Paradis V, Bedossa P, et al. Prospective Comparison of Attenuation Imaging and Controlled Attenuation Parameter for Liver Steatosis Diagnosis in Patients With Nonalcoholic Fatty Liver Disease and Type 2 Diabetes. Clin Gastroenterol Hepatol 2024;22(5):1005-13.e27. https://doi.org/10.1016/j.cgh.2023.11.034.CrossRef Dioguardi Burgio M, Castera L, Oufighou M, Rautou PE, Paradis V, Bedossa P, et al. Prospective Comparison of Attenuation Imaging and Controlled Attenuation Parameter for Liver Steatosis Diagnosis in Patients With Nonalcoholic Fatty Liver Disease and Type 2 Diabetes. Clin Gastroenterol Hepatol 2024;22(5):1005-13.e27. https://​doi.​org/​10.​1016/​j.​cgh.​2023.​11.​034.CrossRef
10.
go back to reference Tada T, Kumada T, Toyoda H, Nakamura S, Shibata Y, Yasuda S, et al. Attenuation imaging based on ultrasound technology for assessment of hepatic steatosis: A comparison with magnetic resonance imaging-determined proton density fat fraction. Hepatol Res 2020;50(12):1319–27. https://doi.org/10.1111/hepr.13563.CrossRefPubMed Tada T, Kumada T, Toyoda H, Nakamura S, Shibata Y, Yasuda S, et al. Attenuation imaging based on ultrasound technology for assessment of hepatic steatosis: A comparison with magnetic resonance imaging-determined proton density fat fraction. Hepatol Res 2020;50(12):1319–27. https://​doi.​org/​10.​1111/​hepr.​13563.CrossRefPubMed
Metadata
Title
The impact of a low-calorie, reduced-fat diet on liver attenuation imaging: a randomized clinical trial
Authors
Renjie Li
Jie Li
Danni He
Yajuan Sui
Wenfen Liu
Wentao Li
Wenyi Meng
Jiahui Peng
Zuofeng Xu
Publication date
18-12-2024
Publisher
Springer US
Published in
Abdominal Radiology
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-024-04762-2

Keynote webinar | Spotlight on advances in lupus

  • Live
  • Webinar | 27-05-2025 | 18:00 (CEST)

Systemic lupus erythematosus is a severe autoimmune disease that can cause damage to almost every system of the body. Join this session to learn more about novel biomarkers for diagnosis and monitoring and familiarise yourself with current and emerging targeted therapies.

Join us live: Tuesday 27th May, 18:00-19:15 (CEST)

Prof. Edward Vital
Prof. Ronald F. van Vollenhoven
Developed by: Springer Medicine
Register now
Webinar

Elevate your expertise in aplastic anemia (Link opens in a new window)

Transform the way you care for your patients with aplastic anemia with our 3-module series using real-world case studies and expert insights. Discover why early diagnosis matters, explore the benefits and risks of current treatments, and develop tailored approaches for complex cases. 

Supported by:
  • Pfizer
Developed by: Springer Healthcare IME
Learn more